Introduced in 2000, Nateglinide belongs to the meglitinides class of drug that is used to lower glucose levels (blood sugar) in type 2 diabetes. Starlix is the brand name, manufactured by Novartis, and it is used along with diet and exercise to treat those who have insulin resistance which leads to high blood sugar levels and typically obesity. Type 2 diabetes is more common than type 1, affecting approximately 90% of all cases of diabetes. Starlix assists the cells in the pancreas to make insulin, and helps the body respond more effectively to that insulin. It is similar to other drugs such as Glynase, Micronase, and Diabeta, but with a faster response time and shorter duration. It is specifically used to lower blood sugar after meals.

What are the Starlix Risks?

Starlix may interact with many different kinds of medications (for example, aspirin, ibuprofen, birth control pills, hormones, …